This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Response to Dextroamphetamine and Tricyclic Antidepressants

Jan Fawcett, MD; James W. Maas, MD; Haroutune Dekirmenjian, PhD

Arch Gen Psychiatry. 1972;26(3):246-251.

Abstract
A study of 12 depressed inpatients shows a significant correlation of improvement with both double-blind administration of dextroamphetamine sulfate and tricyclic antidepressant drug treatment and the low mean baseline excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG). The mean MHPG excretion for six patients with a good response to dextroamphetamine was found to be significantly lower than the mean MHPG level for six nonresponders. Five of six responders showed a slight increase in MHPG excretion with dextroamphetamine while five of six nonresponders showed a modest decrease in MHPG excretion. A correlation coefficient between low mean baseline MHPG excretion and improvement in depression ratings reached .58 (P < .50) for the third week and .84 (P < .01) for the fourth week of tricyclic drug therapy. These findings are discussed in terms of the catecholamine depletion hypothesis of depression and the problem of the prediction of response to tricyclic antidepressant therapy.

Author Affiliations
Chicago

From the Illinois State Psychiatric Institute (Drs. Fawcett, Maas, and Dekirmenjian), and the Department of Psychiatry, Abraham Lincoln School of Medicine (Drs. Fawcett and Maas), Chicago.

Footnotes
Accepted for publication Sept 9, 1971.

Reprint requests to Illinois State Psychiatric Institute, 1601 W Taylor St, Chicago 60612 (Dr. Fawcett).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG)
Keeton et al.
Science 1981;211:586-588.
ABSTRACT  

CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor
Garfinkel et al.
Arch Gen Psychiatry 1977;34:735-739.
ABSTRACT  

Reduced Growth Hormone Responses to Amphetamine in "Endogenous" Depressive Patients: Studies in Normal, "Reactive" and "Endogenous" Depressive, Schizophrenic, and Chronic Alcoholic Subjects
Langer et al.
Arch Gen Psychiatry 1976;33:1471-1475.
ABSTRACT  

Prediction of Tricyclic Antidepressant Response: A Critical Review
Bielski and Friedel
Arch Gen Psychiatry 1976;33:1479-1489.
ABSTRACT  

Biogenic Amines and Depression: Biochemical and Pharmacological Separation of Two Types of Depression
Maas and Maas
Arch Gen Psychiatry 1975;32:1357-1361.
ABSTRACT  

Strain differences during intraventricular infusion of norepinephrine: possible role of receptor sensitivity
Segal et al.
Science 1975;189:301-303.
ABSTRACT  

Overview of Recent Research in Depression: Integration of Ten Conceptual Models Into a Comprehensive Clinical Frame
Akiskal and McKinney
Arch Gen Psychiatry 1975;32:285-305.
ABSTRACT  

Antidepressant Response to Tricyclics and Urinary MHPG in Unipolar Patients: Clinical Response to Imipramine or Amitriptyline
Beckmann and Goodwin
Arch Gen Psychiatry 1975;32:17-21.
ABSTRACT  

Depressive Disorders: Toward a Unified Hypothesis: Clinical, experimental, genetic, biochemical, and neurophysiological data are integrated
Akiskal and McKinney
Science 1973;182:20-29.
ABSTRACT  

Relation of Exercise to MHPG Excretion in Normal Subjects
Goode et al.
Arch Gen Psychiatry 1973;29:391-396.
ABSTRACT